On March 02, 2023 Stefan Göstl, Head of Life Sciences and Chemicals, was elected as successor of Rino Woyczyk, as 1st Vice President of the association "Interessengemeinschaft Pharmabau 3000 e. V."was elected.
The association "Interessengemeinschaft Pharmabau 3000 e. V." – VIP3000 for short – has been specifically promoting technologies in pharmaceutical construction for many years. This includes pharmaceutical process engineering, building services and the construction of production buildings suitable for pharmaceuticals. Leading companies and research institutions from the German-speaking pharmaceutical, chemical and cosmetics industries, their suppliers, planners and universities are involved in the association.
The newly elected VIP3000 Board will shape the work of the association over the next three years. In this sense, he is consistently continuing the work of Rino Woyczyk, Partner at Drees & Sommer SE. For more than two decades, the company has been committed to ensuring that VIP3000 expands its presence in the life sciences industry. This provides members and interested parties with an important platform for exchange.
Stefan Göstl: "The industry and especially we as a service provider are facing changes. All the more reason for us to look forward to actively developing a large network and thus also aligning our company even better to future requirements."
Would you like to learn more about the VIP3000? Click here to go to the website.